Around 1.4-3.8% of boys in the Western world are operated because of cryptorchidism. This means that orchidopexy remains one of the most common surgical procedures performed in boys. As a consequence, several consensus reports, guidelines, and reviews dealing with the management of cryptorchidism have been published recently. Based on our research and 30 years' experience with the management of cryptorchidism, the intention of the present publication is to advise on the surgical management and comment on the expected outcome, especially with focus on the controversies related to guidelines and reviews. Except for late referral and waiting lists, which may be practical problems, there is no reason to postpone orchidopexy for nonsyndromic congenital cryptorchid testes beyond 6 months. There is good evidence that such strategy improves the fertility potential and decreases the risk of testicular cancer. In cases with genuine gonadotropin insufficiency, early surgical correction is not enough and adjuvant LH-RH treatment should be implemented to improve the fertility potential. Cryopreservation may be an option in case of treatment failure of adjuvant LH-RH. A prerequisite for such management includes serum hormone assessment and evaluation of testicular biopsies at orchidopexy. Ascended testes contribute to 20-60% of operative cases and should be treated when diagnosed.

Keywords:
Cryptorchidism, Fertility, Orchidopexy
1.
Agarwal PK, Diaz M, Elder JS: Retractile testis - is it really a normal variant? J Urol 175:1496-1499 (2006).
2.
Allin BSR, Dumann E, Fawkner-Corbett D, Kwok C, Skerritt C, Paediatric Surgery Trainees Research Network: Systematic review and meta-analysis comparing outcomes following orchidopexy for cryptorchidism before or after 1 year of age. BJS Open 2:1-12 (2018).
3.
Atwell JD: Ascent of the testis: fact or fiction. Br J Urol 57:474-477 (1985).
4.
Barthold JS, Gonzalez R: The epidemiology of congenital cryptorchidism, testicular ascent and orchiopexy. J Urol 170:2396-2401 (2003).
5.
Barthold JS, Reinhardt S, Thorup J: Genetic, maternal, and environmental risk factors for cryptorchidism: an update. Eur J Pediatr Surg 26:399-408 (2016).
6.
Bergbrant S, Omling E, Björk J, Hagander L: Cryptorchidism in Sweden: a nationwide study of prevalence, operative management, and complications. J Pediatr 194:197-203 (2018).
7.
Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR: Prevalence and natural history of cryptorchidism. Pediatrics 92:44-49 (1993).
8.
Berney DM, Looijenga LHJ, Idrees M, Oosterhuis JW, Rajpert-De Meyts E, et al: Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular preinvasive germ cell malignancy. Histopathology 69:7-10 (2016).
9.
Bianchi A, Squire BR: Trans scrotal orchidopexy: orchidopexy revised. Pediatr Surg In 4:189-192 (1989).
10.
Blom K: Undescended testis and the time of spontaneous descent in 2516 schoolboys. Ugeskr Laeger 146:616-617 (1984).
11.
Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M, Skakkebaek NE, Toppari J: Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363:1264-1269 (2004).
12.
Clarnette TD, Rowe D, Hasthorpe S, Hutson JM: Incomplete disappearance of the processus vaginalis as a cause of ascending testis. J Urol 157:1889-1891 (1997).
13.
Cortes D: Cryptorchidism - aspects of pathogenesis, histology and treatment. Scand J Urol Nephrol Suppl 196:1-54 (1998).
14.
Cortes D, Thorup JM, Beck BL: Quantitative histology of germ cells in the undescended testes of human fetuses, neonates and infants. J Urol 154:1188-1192 (1995).
15.
Cortes D, Thorup JM, Lindenberg S: Fertility potential after unilateral orchiopexy: simultaneous testicular biopsy and orchiopexy in a cohort of 87 patients. J Urol 155:1061-1065 (1996).
16.
Cortes D, Thorup JM, Visfeldt J: Cryptorchidism: aspects of fertility and neoplasms. A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. Horm Res 55:21-27 (2001).
17.
Cortes D, Petersen BL, Thorup J: Testicular histology in cryptorchid boys - aspects of fertility. J Ped Surg Special 1:32-35 (2007).
18.
Dahl HM, Nerhus TK, Haga OS, Haukaas S: Ascent of the testis. Tidsskr Nor Laegeforen 115:598-600 (1995).
19.
Docimo SG: The results of surgical therapy for cryptorchidism: a literature review and analysis. J Urol 154:1148-1152 (1995).
20.
East Anglia Branch: Cour-Palais IJ: Spontaneous descent of the testicle. Lancet Jun 25:1403-1405 (1966).
21.
Ein SH, Nasr A, Wales PW, Ein A: Testicular atrophy after attempted pediatric orchidopexy for true undescended testis. J Pediatr Surg 49:317-322 (2014).
22.
Elder J: Surgical management of the undescended testis: recent advances and controversies. Eur J Ped Surg 26:418-426 (2016).
23.
Elyas R, Guerra LA, Pike J, DeCarli C, Betolli M, et al: Is staging beneficial for Fowler-Stephens orchiopexy? A systematic review. J Urol 183:2012-2018 (2010).
24.
Faure A, Bouty A, O'Brien M, Thorup J, Hutson J, Heloury Y: Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure? Nat Rev Urol 13:141-150 (2016).
25.
Hadziselimovic F: On the descent of the epididymo-testicular unit, cryptorchidism, and prevention of infertility. Basic Clin Androl 27:21 (2017).
26.
Hadziselimovic F, Zivkovic D, Bica DT, Emmons LR: The importance of mini-puberty for fertility in cryptorchidism. J Urol 174:1536-1539 (2005).
27.
Hutson JM, Li R, Southwell BR, Petersen BL, Thorup J, Cortes D: Germ cell development in the postnatal testis: the key to prevent malignancy in cryptorchidism? Front Endocrinol 3:176 (2013).
28.
Hutson JM, Thorup J, Beasley SW: Classification and causes of undescended testes in humans, in Hutson JM, Thorup J, Beasley SW (eds): Descent of the Testis, pp 45-67 (Springer International Publishing, Switzerland 2016a)
29.
Hutson JM, Thorup J, Beasley SW: Cryptorchidism and associated anomalies, in Hutson JM, Thorup J, Beasley SW (eds): Descent of the Testis, pp 69-80 (Springer International Publishing, Switzerland 2016b).
30.
Hutson JM, Thorup J, Beasley SW: Results of treatment, in Hutson JM, Thorup J, Beasley SW (eds): Descent of the Testis, pp 159-169 (Springer International Publishing, Switzerland 2016c).
31.
John Radcliffe Hospital Study Group: Clinical diagnosis of cryptorchidism. Arch Dis Child 63:587-591 (1988).
32.
John Radcliffe Hospital Cryptorchidism Study Group: Cryptochidism: a prospective study of 7,500 consecutive male births, 1984-8. Arch Dis Child 67:892-899 (1992).
33.
Kelley BP, Higuera S, Cisek LJ, Friedman J, Heller L: Combined laparoscopic and microsurgical techniques for testicular autotransplantation: is this still an evolving technique? J Reconstr Microsurg 26:555-558 (2010).
34.
Kollin C, Karpe B, Hesser U, Granholm T, Ritzén EM: Surgical treatment of unilaterally undescended testes: testicular growth after randomization to orchiopexy at age 9 months or 3 years. J Urol 178:1589-1593 (2007).
35.
Kollin C, Stukenborg JB, Nurmio M, Sundqvist E, Gustafsson T, et al: Boys with undescended testes: endocrine, volumetric and morphometric studies on testicular function before and after orchidopexy at nine months or three years of age. J Clin Endocrinol Metab 97:4588-4595 (2012).
36.
Kolon TF, Herndon CD, Baker LA, Baskin LS, Baxter CG, et al: American Urological Assocation. Evaluation and treatment of cryptorchidism: AUA guideline. J Urol 192:337-345 (2014).
37.
Kutasy B, Thorup JM, Wester T: Comments to recent guidelines on undescended testis. Eur J Pediatr Surg 26:432-435 (2016).
38.
Kvist K, Clasen-Linde E, Langballe O, Hansen SH, Cortes D, Thorup J: The expression of markers for intratubular germ cell neoplasia in normal infantile testes. Front Endocrinol 9:286 (2018).
39.
La Scala GC, Ein SH: Retractile testes: an outcome analysis on 150 patients. J Pediatr Surg 39:1014-1017 (2004).
40.
Lee PA, Houk CP: Cryptorchidism. Curr Opin Endocrinol Diabetes Obes 20:210-216 (2013).
41.
Lip SZL, Murchison LED, Cullis PS, Govan L, Carachi R: A metaanalysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child 98:20-26 (2013).
42.
Mayr J, Rune GM, Holas A, Schimpl G, Schmidt B, Haberlik A: Ascent of the testis in children. Eur J Pediatr 154:893-895 (1995).
43.
Moller H: Epidemiological studies of testicular germ cell cancer (Thames Cancer Registry, Kings College, London 2001).
44.
Niedzielski JK, Oszukowska E, Słowikowska-Hilczer J: Undescended testis - current trends and guidelines: a review of the literature. Arch Med Sci 12:667-677 (2016).
45.
Osterballe L, Clasen-Linde E, Cortes D, Engholm G, Hertzum-Larsen R, et al: The diagnostic impact of testicular biopsies for intratubular germ cell neoplasia in cryptorchid boys and the subsequent risk of testicular cancer in men with prepubertal surgery for syndromic or non-syndromic cryptorchidism. J Pediatr Surg 52:587-592 (2017).
46.
Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O: Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356:1835-1841 (2007).
47.
Peycelon M, Rossignol G, Muller CO, Carricaburu E, Philippe-Chomette P, et al: Testicular prostheses in children: is earlier better? J Pediatr Urol 12:237.e1-6 (2016).
48.
Preiksa RT, Zilaitiene B, Matulevicius V, Skakkebaek NE, Petersen JH, Jørgensen N, Toppari J: Higher than expected prevalence of congenital cryptorchidism in Lithuania: a study of 1204 boys at birth and 1 year follow-up. Hum Reprod 20:1928-1932 (2005).
49.
Rabinowitz R, Hulbert Jr WC: Late presentation of cryptorchidism: the etiology of testicular re-ascent. J Urol 157:1892-1894 (1997).
50.
Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, et al: Corrigendum to ‘Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines'. J Pediatr Urol 13:239 (2017).
51.
Rajpert-De Meyts E: Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 12:303-323 (2006).
52.
Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, et al: Nordic consensus on treatment of undescended testes. Acta Paediatr 96:638-643 (2007).
53.
Sadov S, Koskenniemi JJ, Virtanen HE, Perheentupa A, Petersen JH, et al: Testicular growth during puberty in boys with and without a history of congenital cryptorchidism. J Clin Endocrinol Metab 101:2570-2577 (2016).
54.
Schindler AM, Diaz P, Cuendet A, Sizonenko PC: Cryptorchidism: a morphological study of 670 biopsies. Helv Paediatr Acta 42:145-158 (1987).
55.
Scorer CG: The descent of the testis. Arch Dis Child 39:605-609 (1964).
56.
Sekaran P, O'Toole S, Flett M, Salvatore C: Increased occurrence of disorders of sex development, prematurity and intrauterine growth restriction in children with proximal hypospadias associated with undescended testes. J Urol 189:1892-1896 (2013).
57.
Shehata SM: Laparoscopically assisted gradual controlled traction on the testicular vessels: a new concept in the management of abdominal testis. A preliminary report. Eur J Ped Surg 18:402-406 (2008).
58.
Shepard L, Kraft KH: The nonpalpable testis: a narrative review. J Urol 198:1410-1417 (2017).
59.
Sijstermans K, Hack WW, Meijer RW, van der Voort-Doedens LM: The frequency of undescended testis from birth to adulthood: a review. Int J Androl 31:1-11 (2008).
60.
Silber SJ, Kelly J: Successful autotransplantation of an intraabdominal testis to the scrotum by microvascular technique. J Urol 115:452-454 (1976).
61.
Tackett LD, Wacksman J, Billmire D, Sheldon CA, Minevich E: The high intra-abdominal testis: technique and long-term success of laparoscopic testicular autotransplantation. J Endourol 16:359-361 (2002).
62.
Taran I, Elder JS: Results of orchiopexy for the undescended testis. World J Urol 24:231-239 (2006).
63.
Tekgül S, Dogan HS, Hoebeke P, Radmayr C, Bogaert G, et al: Management of undescended testes - European Association of Urology/European Society for Paediatric Urology guidelines. Available at: http://uroweb.org/guideline/paediatric-urology/ (accessed July 2018)
64.
Thorup J, Cortes D: The incidence of maldescended testes in Denmark. Pediatr Surg Int 5:2-5 (1990).
65.
Thorup J, Petersen BL, Kvist K, Cortes D: Bilateral vanished testes diagnosed with a single blood sample showing very high gonadotropins (follicle-stimulating hormone and luteinizing hormone) and very low inhibin B. Scand J Urol Nephrol 45:425-31 (2011a).
66.
Thorup J, Jensen CL, Langballe O, Petersen BL, Cortes D:The challenge of early surgery for cryptorchidism. Scand J Urol Nephrol 45:184-189 (2011b).
67.
Thorup J, Petersen BL, Kvist K, Cortes D: Bilateral undescended testes classified according to preoperative and postoperative status of gonadotropins and inhibin B in relation to testicular histopathology at bilateral orchiopexy in infant boys. J Urol 188(4 Suppl):1436-1442 (2012).
68.
Thorup J, Kvist K, Clasen-Linde E, Petersen BL, Cortes D: The relation between adult dark spermatogonia and other parameters of fertility potential in cryptorchid testes. J Urol 190:1566-1571 (2013).
69.
Thorup J, Clasen-Linde E, Thorup SC, Cortes D: Pre- and postoperative status of gonadotropins (FSH and LH) and inhibin-B in relation to testicular histopathology at orchiopexy in infant boys with unilateral undescended testes. J Pediatr Urol 11:25.e1-5 (2015).
70.
Thorup J, Clasen-Linde E, Cortes D: Positive Oct-3/4 and D2-40 immunohistochemical expression in germ cells and suspected histology pattern of intratubular germ cell neoplasia in boys with cryptorchidism vanish after the age of 2 years. Eur J Pediatr Surg 27:313-318 (2017).
71.
Thorup J, Clasen-Linde E, Li R, Reinhardt S, Kvist K, et al: Postnatal germ cell development in the cryptorchid testis: the key to explain why early surgery decreases the risk of malignancy. Eur J Pediatr Surg 28:469-476 (2018a).
72.
Thorup J, Clasen-Linde E, Dong L, Hildorf S, Kristensen SG, et al: Selecting infants with cryptorchidism and high risk of infertility for optional adjuvant hormonal therapy and cryopreservation of germ cells: experience from a pilot study. Front Endocrinol 9:299 (2018b).
73.
Villumsen AL, Zachau-Christiansen B: Spontaneous alterations in position of the testes. Arch Dis Child 41:198-200 (1966).
74.
Ward B, Hunter WM: The absent testicle. A report on a survey carried out among schoolboys in Nottingham. Br Med J 9:1110-1111 (1960).
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.